Pamela Kimball

1.5k total citations
56 papers, 1.0k citations indexed

About

Pamela Kimball is a scholar working on Transplantation, Surgery and Epidemiology. According to data from OpenAlex, Pamela Kimball has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Transplantation, 16 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in Pamela Kimball's work include Renal Transplantation Outcomes and Treatments (19 papers), Transplantation: Methods and Outcomes (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Pamela Kimball is often cited by papers focused on Renal Transplantation Outcomes and Treatments (19 papers), Transplantation: Methods and Outcomes (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Pamela Kimball collaborates with scholars based in United States, Canada and France. Pamela Kimball's co-authors include Michael G. Brattain, A M Pitts, Anne L. King, Theresa P. Pretlow, T G Pretlow, Emily A. Boohaker, AA Bartolucci, Michael Marks, Thomas G. Pretlow and Gaurav Gupta and has published in prestigious journals such as Cancer, Cancer Research and Biochemical Journal.

In The Last Decade

Pamela Kimball

56 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Kimball United States 18 306 292 234 208 169 56 1.0k
Stipo Jurčević United Kingdom 18 268 0.9× 243 0.8× 596 2.5× 218 1.0× 124 0.7× 47 1.1k
G. Monga Italy 18 114 0.4× 116 0.4× 98 0.4× 220 1.1× 123 0.7× 54 948
Norio Hirabayashi Japan 14 173 0.6× 92 0.3× 138 0.6× 132 0.6× 158 0.9× 41 820
Sindhu Chandran United States 16 165 0.5× 297 1.0× 232 1.0× 236 1.1× 264 1.6× 43 1.0k
Giuseppe Aimo Italy 16 190 0.6× 110 0.4× 63 0.3× 92 0.4× 108 0.6× 44 749
Milagros Lagman United States 11 440 1.4× 370 1.3× 292 1.2× 502 2.4× 605 3.6× 19 1.6k
Janeth C. Villanueva United States 18 370 1.2× 164 0.6× 510 2.2× 359 1.7× 140 0.8× 29 1.4k
André Hoerning Germany 15 114 0.4× 83 0.3× 357 1.5× 207 1.0× 297 1.8× 57 887
Takahito Moriyama Japan 23 154 0.5× 64 0.2× 203 0.9× 230 1.1× 116 0.7× 102 1.6k
Hirohito Yamazaki Japan 21 74 0.2× 85 0.3× 692 3.0× 79 0.4× 251 1.5× 95 1.4k

Countries citing papers authored by Pamela Kimball

Since Specialization
Citations

This map shows the geographic impact of Pamela Kimball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Kimball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Kimball more than expected).

Fields of papers citing papers by Pamela Kimball

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Kimball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Kimball. The network helps show where Pamela Kimball may publish in the future.

Co-authorship network of co-authors of Pamela Kimball

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Kimball. A scholar is included among the top collaborators of Pamela Kimball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Kimball. Pamela Kimball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kimball, Pamela, Jean‐Sébastien Casalegno, Pamela P. Martinez, et al.. (2025). Urban contact patterns shape respiratory syncytial virus epidemics with implications for vaccination. Science Advances. 11(48). eady5457–eady5457. 1 indexed citations
2.
Kumar, Dhiren, Irfan Moinuddin, Alexandra Bryson, et al.. (2020). Coronavirus Disease 2019 Viremia, Serologies, and Clinical Course in a Case Series of Transplant Recipients. Transplantation Proceedings. 52(9). 2637–2641. 13 indexed citations
3.
Kimball, Pamela, et al.. (2017). Circulating angiotensin type II receptor: Possible marker for antibody mediated rejection after renal transplantation?. Human Immunology. 78(10). 629–633. 7 indexed citations
4.
Kumar, Dhiren, et al.. (2016). Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.. PubMed. 32. 143–151. 1 indexed citations
5.
Gupta, Gaurav, Dhiren Kumar, M. P. Posner, et al.. (2015). Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. American Journal of Transplantation. 15(10). 2726–2731. 47 indexed citations
6.
Kimball, Pamela, et al.. (2011). Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection. Kidney International. 79(10). 1131–1137. 54 indexed citations
7.
Kimball, Pamela, et al.. (2011). A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.. PubMed. 369–72. 1 indexed citations
8.
Kimball, Pamela, et al.. (2007). Quantitation of Alloantibody Concentration Can Predict Patient Sensitivity to Intravenous Immunoglobulin Desensitization. Transplantation. 84(11). 1540–1543. 2 indexed citations
9.
Kimball, Pamela & Anne L. King. (2006). Desensitized Renal Transplant Recipients Show Reduced Cellular Responses to In Vitro Challenge. Transplantation Proceedings. 38(10). 3416–3417. 3 indexed citations
10.
Chang, Seong‐Hwan, et al.. (2004). Living donor liver transplant with clinical tolerance, laboratory evidence of chimerism, and spontaneous clearance of HBV. Liver Transplantation. 10(11). 1432–1435. 2 indexed citations
11.
Kimball, Pamela, et al.. (2001). Influenza vaccination among heart transplant recipients. Transplantation Proceedings. 33(1-2). 1785–1786. 10 indexed citations
12.
13.
Vaidya, Smita, et al.. (2000). FREQUENCY, POTENTIAL RISK AND THERAPEUTIC INTERVENTION IN END-STAGE RENAL DISEASE PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME. Transplantation. 69(7). 1348–1352. 63 indexed citations
14.
Kimball, Pamela, et al.. (1996). THE PARADOX OF CYTOKINE MONITORING-PREDICTOR OF IMMUNOLOGIC ACTIVITY AS WELL AS IMMUNOLOGIC SILENCE FOLLOWING CARDIAC TRANSPLANTATION. Transplantation. 61(6). 909–915. 29 indexed citations
15.
Tolman, Dan E., et al.. (1996). Disproportionate HLA matching may contribute to racial disparity in patient survival following cardiac transplantation. Clinical Transplantation. 10(6pt2). 625–628. 14 indexed citations
16.
Kimball, Pamela, Ronald H. Kerman, & Barry D. Kahan. (1991). FAILURE OF PROLYL-PEPTIDYL ISOMERASE TO MEDIATE CYCLOSPORINE SUPPRESSION OF INTRACELLULAR ACTIVATION SIGNAL GENERATION. Transplantation. 51(2). 509–513. 6 indexed citations
17.
Kimball, Pamela, et al.. (1988). Two episodes of calcium uptake associated with T-lymphocyte activation. Cellular Immunology. 113(1). 107–116. 17 indexed citations
18.
Brattain, Michael G., et al.. (1981). Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts.. PubMed. 2(5). 355–66. 71 indexed citations
19.
Kimball, Pamela & Michael G. Brattain. (1980). Isolation of a cellular subpopulation from a human colonic carcinoma cell line.. PubMed. 40(5). 1574–9. 42 indexed citations
20.
Kimball, Pamela & Michael G. Brattain. (1978). A comparison of methods for the isolation of carcinoembryonic antigen.. PubMed. 38(3). 619–23. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stipo Jurčević Breakdown of academic impact, for papers by G. Monga Breakdown of academic impact, for papers by Norio Hirabayashi Breakdown of academic impact, for papers by Sindhu Chandran Breakdown of academic impact, for papers by Giuseppe Aimo Breakdown of academic impact, for papers by Milagros Lagman Breakdown of academic impact, for papers by Janeth C. Villanueva Breakdown of academic impact, for papers by André Hoerning Breakdown of academic impact, for papers by Takahito Moriyama Breakdown of academic impact, for papers by Hirohito Yamazaki
Rankless by CCL
2026